ArticleClinical pharmacology and therapeutics2026

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.

Vasiliki Kostiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.